Shlomo Maayan, MD, Director of the Hadassah AIDS Center, in Jerusalem, Israel, discusses new Anti-AIDS drug treatments available, including Anti-AIDS gels and Anti-AIDS preventative drugs. For more information…
Shlomo Maayan, MD, Director of the Hadassah AIDS Center, in Jerusalem, Israel, discusses relevant statistics regarding AIDS in Africa and elsewhere. For more information on ICAMiA’s important work…
Shlomo Maayan, MD, Director of the Hadassah AIDS Center, in Jerusalem, Israel, discusses his work with the Israel Consortium on AIDS Medicine in Africa (ICAMiA) and the importance…
NEW YORK (Reuters Health) – People with HIV treated at outpatient clinics may be at an increased risk of bone fractures, according to a new study published in…
NEW YORK (Reuters Health) – Clinical practice guidelines on the management of hepatitis C infection, issued by the European Association for the Study of the Liver, underscore the…
NEW YORK (Reuters Health) — Chronically HIV-infected individuals show brain damage even when the disease is otherwise stable because of highly active antiretroviral therapy (HAART), according to a…
NEW YORK (Reuters Health) – For initial treatment of HIV-1 infection, once daily atazanavir plus ritonavir and once-daily efavirenz provide comparable antiviral efficacy when used with either abacavir/lamivudine…
Rosuvastatin should be considered for HIV-positive people with dyslipidemia — and guidelines should be updated to reflect that, suggests a new study. Although guidelines from the Infectious Diseases…
NEW YORK (Reuters Health) – HIV patients whose regimen includes efavirenz and who experience CNS side effects such as insomnia and nervousness may benefit from a switch to…
NEW YORK (Reuters Health) – The characteristic loss of facial fat in many patients being treated for HIV infection can be effectively rectified with autologous fat transplantation or…